Analyst Ratings for Monte Rosa Therapeutics (GLUE)
GLUE Rating Summary
GLUE Price Target Summary
- Highest: $37.00 (Piper Sandler)
- Lowest: $26.00 (Wedbush)
- Average: $31.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.60 (+77.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$31.60 (+77.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/16/2025 | Wells Fargo » Updated 1/8/2026 |
Derek Archila | Upgrade | Overweight (Equal Weight) |
30.00 (22.00) |
16.45 (17.80) |
8.21% | Details |
| 3/12/2025 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
19.00 (N/A) |
6.11 (17.80) |
191.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
